Air Leakage Under Continuous Positive Airway Pressure
SAS-leak-1
Retrospective Analysis of the Determinants of Air Leakage in a Population of Obstructive Sleep Apnea Syndrome Treated With Continuous Positive Airway Pressure
1 other identifier
observational
79
1 country
3
Brief Summary
The software embedded in recent continuous positive pressure devices enables the analysis of the level of leakage that occurs during treatment around the mask or from the mouth. However, there is no clear threshold defining when it would be appropriate to implement means for correcting these leaks. In addition, the calculation methods used to detect/measure leaks and the terminology used vary according to the manufacturers of continuous pressure devices, which also complicates the clinical interpretation of the leakage reports provided by the various devices. In daily practice, when a patient complains of unintentional leakage, technicians adjust the mask, replace the nasal-mask by an oro-nasal mask or install a chinstrap. Nevertheless, those strategies are not always effective in reducing leakage or patient's complaints. A better understanding of the mechanisms beyond leak appearance for a given patient could lead to individualised leak-treatment solutions. Pressure level, mandibular behaviour, respiratory effort, sleep position or sleep stages may contribute to leak emergence. A recent exploratory study has proposed a genuine analysis method of determining factors of unintentional-leaks using polysomnographic recordings in OSA patients treated with automatic Continuous Positive Airway Pressure (auto-CPAP). Based on the same methodology, the NOMICS company (Liège, Belgium) has developed a polygraphic device (Brizzy®) recording unintentional leakage during auto-CPAP treatment and providing an etiological analysis of unintentional-leaks via a software named APIOS. Due to the innovative nature of the analysis, it appears necessary to validate it onto a population of OSA patients treated with auto-CPAP. Also, to our knowledge, there is no descriptive data of the distribution of the determinants of unintentional leaks in such a population. From this perspective, the investigators aim to retrospectively analyse some polygraphic recordings that have been performed with the Brizzy® on OSA patients treated with auto-CPAP. The primary objective of this study is to identify and describe the determinants of unintentional leaks for a population of patients with OSA and treated with an auto-CPAP device
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2017
CompletedFirst Posted
Study publicly available on registry
December 22, 2017
CompletedStudy Start
First participant enrolled
January 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2018
CompletedJuly 2, 2020
June 1, 2020
3 months
December 18, 2017
June 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Mouth-opening odds ratio
For each patient presenting with an unintentional leak, determination of odds ratios for mouth-opening.
day 0 (transversal study)
Auto-CPAP pressure level odds ratio
For each patient presenting with an unintentional leak, determination of odds ratios for Auto-CPAP pressure level
day 0 (transversal study)
Sleep position odds ratio
For each patient presenting with an unintentional leak, determination of odds ratios for sleep position
day 0 (transversal study)
Respiratory effort (increase in the Jawac signal > 0.3 mm) odds ratio
For each patient presenting with an unintentional leak, determination of odds ratios respiratory effort
day 0 (transversal study)
Secondary Outcomes (5)
Epworth scale score
day 0 (transversal study)
Pichot scale
day 0 (transversal study)
Occurrence of nasal obstruction
day 0 (transversal study)
Occurrence of mouth dryness
day 0 (transversal study)
Occurrence of nasal dryness
day 0 (transversal study)
Other Outcomes (10)
Type/brand of mask and device used
day 0 (transversal study)
Presence of heated humidifier
day 0 (transversal study)
Presence of chinstraps.
day 0 (transversal study)
- +7 more other outcomes
Study Arms (1)
The study population
The study population corresponds to patients with obstructive sleep apnea syndrome treated via continuous positive pressure and monitored according to usual practice with the latest Brizzy device. Intervention: Brizzy continuous positive pressure device
Interventions
Patients are treated with the Brizzy continuous positive pressure device, including pneumotachograph.
Eligibility Criteria
The study population corresponds to patients (all meeting eligibility criteria) with obstructive sleep apnea syndrome treated via continuous positive pressure and monitored according to usual practice with the latest Brizzy device.
You may qualify if:
- Sleep recordings from patients with OSA treated via auto-CPAP and monitored with Brizzy® device (including measures of non-intentional leaks) between June 1st and December 31th, 2017.
You may not qualify if:
- The patient opposes the usage of his/her data
- Minors or adults under any kind of guardianship
- Fixed pressure
- Bilevel positive airway pressure devices
- Adaptive servo-ventilation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Polyclinic Saint-Privat
Boujan-sur-Libron, 34760, France
University Hospital of Grenoble
Grenoble, France
Hôpital Arnaud de Villeneuve
Montpellier, France
Related Publications (2)
Lebret M, Arnol N, Martinot JB, Lambert L, Tamisier R, Pepin JL, Borel JC. Determinants of Unintentional Leaks During CPAP Treatment in OSA. Chest. 2018 Apr;153(4):834-842. doi: 10.1016/j.chest.2017.08.017. Epub 2017 Aug 26.
PMID: 28847549RESULTLebret M, Jaffuel D, Suehs CM, Mallet JP, Lambert L, Rotty MC, Pepin JL, Matzner-Lober E, Molinari N, Borel JC. Feasibility of Type 3 Polygraphy for Evaluating Leak Determinants in CPAP-Treated OSA Patients: A Step Toward Personalized Leak Management. Chest. 2020 Nov;158(5):2165-2171. doi: 10.1016/j.chest.2020.05.593. Epub 2020 Jun 13.
PMID: 32544491RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Christian Borel, PhD
University Hospital, Grenoble
- STUDY DIRECTOR
Nicolas Molinari, PhD
University Hospital, Montpellier
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2017
First Posted
December 22, 2017
Study Start
January 10, 2018
Primary Completion
April 20, 2018
Study Completion
April 20, 2018
Last Updated
July 2, 2020
Record last verified: 2020-06